Drug Profile
Research programme: H5N1 avian influenza virus vaccine - PowderMed
Alternative Names: H5N1 avian influenza virus vaccine research programme - PowderMedLatest Information Update: 04 Aug 2009
Price :
$50
*
At a glance
- Originator PowderMed
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 04 Aug 2009 No development reported - Preclinical for Influenza virus infections in United Kingdom (Intradermal)
- 01 Sep 2005 Preclinical trials in Influenza virus infections in United Kingdom (Intradermal)